TLRY vs UFPT · rev $915.5M vs P/E 26, rev $148.9M
Tilray Inc (TLRY) versus UFP Technologies Inc (UFPT) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
UFP Technologies Inc (UFPT) is a medical devices company listed on NASDAQ.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported UFPT revenue for 2025-12-31 was $148.9M. Net income was $17.6M. Revenue was down 1.5% from 2025-06-30 to 2025-12-31. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
TLRY currently screens at market cap $573.9M. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
Not investment advice. Open the TLRY and UFPT stock pages for the full models.
Not investment advice.